New Zealand markets close in 3 hours 27 minutes

Thermo Fisher Scientific Inc. (TMO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
522.93+15.74 (+3.10%)
At close: 04:00PM EDT
524.28 +1.35 (+0.26%)
After hours: 07:49PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 202.40B
Enterprise value 230.77B
Trailing P/E 27.49
Forward P/E 21.19
PEG ratio (5-yr expected) 3.10
Price/sales (ttm)4.77
Price/book (mrq)4.79
Enterprise value/revenue 5.39
Enterprise value/EBITDA 19.11

Trading information

Stock price history

Beta (5Y monthly) 0.86
52-week change 3-10.86%
S&P500 52-week change 3-16.62%
52-week high 3672.34
52-week low 3497.83
50-day moving average 3564.23
200-day moving average 3567.18

Share statistics

Avg vol (3-month) 31.2M
Avg vol (10-day) 31.27M
Shares outstanding 5391.79M
Implied shares outstanding 6N/A
Float 8390.66M
% held by insiders 10.38%
% held by institutions 190.58%
Shares short (14 Sept 2022) 43.14M
Short ratio (14 Sept 2022) 43.14
Short % of float (14 Sept 2022) 40.80%
Short % of shares outstanding (14 Sept 2022) 40.80%
Shares short (prior month 14 Aug 2022) 42.82M

Dividends & splits

Forward annual dividend rate 41.2
Forward annual dividend yield 40.24%
Trailing annual dividend rate 31.12
Trailing annual dividend yield 30.22%
5-year average dividend yield 40.23
Payout ratio 45.96%
Dividend date 313 Oct 2022
Ex-dividend date 413 Sept 2022
Last split factor 23:2
Last split date 305 Jun 1996

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)01 Jul 2022

Profitability

Profit margin 17.37%
Operating margin (ttm)22.77%

Management effectiveness

Return on assets (ttm)7.70%
Return on equity (ttm)18.78%

Income statement

Revenue (ttm)42.82B
Revenue per share (ttm)108.96
Quarterly revenue growth (yoy)18.30%
Gross profit (ttm)19.64B
EBITDA 12.76B
Net income avi to common (ttm)7.44B
Diluted EPS (ttm)18.79
Quarterly earnings growth (yoy)-9.00%

Balance sheet

Total cash (mrq)1.89B
Total cash per share (mrq)4.82
Total debt (mrq)30.26B
Total debt/equity (mrq)71.25
Current ratio (mrq)1.65
Book value per share (mrq)107.95

Cash flow statement

Operating cash flow (ttm)8.84B
Levered free cash flow (ttm)5.61B